News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,506 Results
Type
Article (40792)
Company Profile (289)
Press Release (654425)
Section
Business (205223)
Career Advice (2023)
Deals (35525)
Drug Delivery (89)
Drug Development (81235)
Employer Resources (168)
FDA (16180)
Job Trends (14878)
News (346595)
Policy (32583)
Tag
Academia (2600)
Alliances (49806)
Alzheimer's disease (1298)
Approvals (16143)
Artificial intelligence (163)
Bankruptcy (355)
Best Places to Work (11654)
Biotechnology (203)
Breast cancer (204)
Cancer (1527)
Cardiovascular disease (121)
Career advice (1686)
CAR-T (106)
Cell therapy (314)
Clinical research (65110)
Collaboration (568)
Compensation (307)
COVID-19 (2579)
C-suite (137)
Data (1471)
Diabetes (189)
Diagnostics (6340)
Earnings (85195)
Employer resources (146)
Events (111031)
Executive appointments (484)
FDA (16954)
Funding (517)
Gene therapy (216)
GLP-1 (621)
Government (4356)
Healthcare (18833)
Infectious disease (2676)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16451)
Job creations (3642)
Job search strategy (1437)
Layoffs (424)
Legal (7881)
Lung cancer (226)
Manufacturing (214)
Medical device (13264)
Medtech (13269)
Mergers & acquisitions (19338)
Metabolic disorders (493)
Neuroscience (1661)
NextGen: Class of 2025 (6554)
Non-profit (4518)
Northern California (1868)
Obesity (281)
Opinion (188)
Patents (133)
People (57086)
Phase I (20292)
Phase II (28675)
Phase III (21341)
Pipeline (614)
Postmarket research (2569)
Preclinical (8675)
Radiopharmaceuticals (243)
Rare diseases (287)
Real estate (5940)
Regulatory (21891)
Research institute (2379)
Resumes & cover letters (354)
Southern California (1622)
Startups (3610)
United States (16685)
Vaccines (581)
Weight loss (194)
Date
Today (126)
Last 7 days (402)
Last 30 days (1975)
Last 365 days (35031)
2025 (1720)
2024 (35427)
2023 (40271)
2022 (51389)
2021 (55965)
2020 (54361)
2019 (46836)
2018 (35230)
2017 (32379)
2016 (31794)
2015 (37877)
2014 (31559)
2013 (26732)
2012 (28903)
2011 (29571)
2010 (27635)
Location
Africa (724)
Arizona (203)
Asia (37798)
Australia (6199)
California (4262)
Canada (1554)
China (362)
Colorado (190)
Connecticut (206)
Europe (81600)
Florida (605)
Georgia (147)
Illinois (416)
Indiana (243)
Maryland (691)
Massachusetts (3291)
Michigan (183)
Minnesota (319)
New Jersey (1184)
New York (1204)
North Carolina (787)
Northern California (1868)
Ohio (154)
Pennsylvania (1001)
South America (1104)
Southern California (1622)
Texas (620)
Utah (119)
Washington State (431)
695,506 Results for "molecular templates inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Molecular Templates, Inc. Provides Interim Update
Molecular Templates, Inc. today provided an update on its clinical-stage programs.
June 3, 2024
·
7 min read
Drug Development
Molecular Templates, Inc. Provides Interim Update
Molecular Templates, Inc. today provided an update on its programs.
March 4, 2024
·
9 min read
Business
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results and business updates for the first quarter of 2024.
May 15, 2024
·
6 min read
Business
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”) today reported financial results for the fourth quarter and full year ended December 31, 2023.
March 29, 2024
·
13 min read
Business
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”) today reported financial results and business updates for the third quarter of 2023.
November 13, 2023
·
12 min read
Press Releases
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
August 15, 2024
·
9 min read
Lone Star Bio
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel therapeutics with potent and differentiated mechanisms of action for cancer, announced participation in the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference.
February 8, 2024
·
3 min read
Lone Star Bio
Molecular Templates to Participate in Upcoming November 2023 Investor Conferences
Molecular Templates, Inc. announced participation in the following upcoming investor conferences.
November 1, 2023
·
3 min read
Press Releases
FESARIUSTHERAPEUTICS INC ANNOUNCES FDA 510(K) CLEARANCE FOR DERMISPHERE HYDROGEL DERMAL REGENERATION TEMPLATE
January 8, 2025
·
3 min read
Press Releases
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements
December 3, 2024
·
4 min read
1 of 69,551
Next
